WHO ICTRP trial
A European Multicenter Open-label Study of Breakthrough Cancer Pain: Assessment…
EUCTR2008-001841-24-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-001841-24-GB |
|---|---|
| Public title | A European Multicenter Open-label Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients |
| Scientific title | A European Multicenter Open-label Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients |
| Primary sponsor | Cephalon France |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany;United Kingdom;Netherlands;France;Spain;Ireland;Italy |
| Conditions | Breakthrough Pain (BTP) in cancer patients MedDRA version: 9.1 Level: LLT Classification code 10064556 Term: Breakthrough pain |
| Interventions | Trade Name: Effentora Pharmaceutical Form: Buccal tablet INN or Proposed INN: Fentanyl Citrate CAS Number: 990-73-8 Current Sponsor code: CEP-25608 Concentration unit: µg microgram(s) Concentration type: equal Concentration number: 100… |
| Registration date | May 16, 2008 |
| Target size | 1200 |
| Secondary IDs | C25608/4027/BP/EU |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: